Benzinga's Volume Movers

surged 18.16% to $17.31. The volume of Adamas Pharmaceuticals shares traded 5466% higher than normal. The FDA approved a New Drug Application for Adamas Pharmaceuticals' Namzaric for the treatment of moderate to severe dementia of the Alzheimer's type.

shares climbed 4.86% to $23.97. The volume of Brookfield Residential Properties shares traded was 786% higher than normal.

announced its plans to acquire remaining 30.6% of Brookfield Residential shares for $24.25 per share in cash.

shares rose 7.54% to $19.25. The volume of Navigator Holdings shares traded was 385% higher than normal. Navigator shares gained on positive Jim Cramer/Mad Money comments.

shares moved up 7.06% to $14.56. The volume of Carbonite traded was 347% higher than normal.

will commence cash tender offer for Carbonite at $15.00 per share.